The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
4-((1-(2,5-Dimethoxyphenyl)-5-methyl-1H-1,2,3-triazol-4-yl)sulfonyl)benzoic Acid ID: ALA4876742
PubChem CID: 164628700
Max Phase: Preclinical
Molecular Formula: C18H17N3O6S
Molecular Weight: 403.42
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: COc1ccc(OC)c(-n2nnc(S(=O)(=O)c3ccc(C(=O)O)cc3)c2C)c1
Standard InChI: InChI=1S/C18H17N3O6S/c1-11-17(28(24,25)14-7-4-12(5-8-14)18(22)23)19-20-21(11)15-10-13(26-2)6-9-16(15)27-3/h4-10H,1-3H3,(H,22,23)
Standard InChI Key: SAPSNJYHXYUMBH-UHFFFAOYSA-N
Molfile:
RDKit 2D
28 30 0 0 0 0 0 0 0 0999 V2000
8.0151 -21.3336 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.3052 -20.9209 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
7.3042 -21.7405 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.0527 -19.4227 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.0516 -20.2464 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.7638 -20.6553 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.4775 -20.2459 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.4747 -19.4191 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.7620 -19.0097 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1860 -20.6514 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.2727 -21.4681 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.0765 -21.6368 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.4840 -20.9243 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9320 -20.3179 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.7595 -18.1884 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.4701 -17.7777 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.7636 -21.4766 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.0516 -21.8892 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.1048 -19.5142 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.7150 -20.2116 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.5369 -20.2122 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.9425 -19.4995 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.5310 -18.7884 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.7055 -18.7944 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2994 -19.5076 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.9367 -18.0790 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.7538 -18.0756 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.5251 -17.3730 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 2 0
4 5 2 0
5 6 1 0
6 7 2 0
7 8 1 0
8 9 2 0
9 4 1 0
10 11 1 0
11 12 2 0
12 13 1 0
13 14 2 0
14 10 1 0
7 10 1 0
9 15 1 0
15 16 1 0
6 17 1 0
17 18 1 0
14 19 1 0
13 2 1 0
2 20 1 0
20 21 2 0
21 22 1 0
22 23 2 0
23 24 1 0
24 25 2 0
25 20 1 0
23 26 1 0
26 27 2 0
26 28 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 403.42Molecular Weight (Monoisotopic): 403.0838AlogP: 2.12#Rotatable Bonds: 6Polar Surface Area: 120.61Molecular Species: ACIDHBA: 8HBD: 1#RO5 Violations: ┄HBA (Lipinski): 9HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: 3.50CX Basic pKa: ┄CX LogP: 2.77CX LogD: -0.61Aromatic Rings: 3Heavy Atoms: 28QED Weighted: 0.66Np Likeness Score: -1.40
References 1. Li Y, Lin W, Wright WC, Chai SC, Wu J, Chen T.. (2021) Building a Chemical Toolbox for Human Pregnane X Receptor Research: Discovery of Agonists, Inverse Agonists, and Antagonists Among Analogs Based on the Unique Chemical Scaffold of SPA70., 64 (3.0): [PMID:33497575 ] [10.1021/acs.jmedchem.0c02201 ]